Phenolic compounds in peaches, plums kill breast cancer cells

NewsGuard 100/100 Score

A recent study performed at Texas A&M University revealed that peaches and plums may present an even sweeter, juicier treat in their ability to fight breast cancer. According to research scientists Dr. Luis Cisneros-Zevallos and Dr. David Byrne from AgriLife Research at Texas A&M, extracts found in commercial varieties of peaches and plums have been shown to kill breast cancer cells while not harming normal cells.

The AgriLife research scientists identified two phenolic compounds within the Rich Lady peach and Black Splendor plum that are responsible for killing the cancer cells. Phenols are organic compounds that occur in fruits and may affect traits such as aroma, taste or color. Stone fruits such as peaches and plums have especially high levels of phenols.

The objective of the study was to evaluate the cancer suppression activity of extracts from a commercial variety of a yellow-fleshed peach and a red-fleshed plum and identify the phenolic fractions that may possess potential as chemopreventive and/or chemotherapeutic natural compounds. Based on analysis of phenolic compounds, both peach and plum extracts effectively inhibited the proliferation of the estrogen independent MDA-MB-435 breast cancer cells while not affecting normal cells.

The researchers concluded that the phenolic compounds examined in breast cancer and normal cells (in-vitro studies) and confirmed in mice models (in-vivo studies) have potential as chemopreventive dietary compounds, however, more research is required before understanding this application to humans.

SOURCE Texas A&M University

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels